Diabetic retinopathy appears to be more common in young people than earlier thought, leaving more of them at risk for eye ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Google’s AI model helps detect and diagnose early signs of diabetic retinopathy, supporting doctors in delivering prompt ...

Diabetic retinopathy, a diabetes complication that affects the eyes is among the leading causes of preventable blindness and ...

Cataracts, dry eyes, glaucoma, and other eye problems become more common with age. But these can be treated and even cured if ...

Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...

Early screening can prevent vision loss in diabetic patients, says ABHI SINGHAL There are over 101 million people affected ...

Google Health has partnered with Forus Health, AuroLab and Perceptra, who will work on securing local regulatory approvals in ...

Christina Y Weng, MD, MBA sat down to discuss the Retina Ophthalmic Technology Assessment Symposium and her journal on ...

A minorities-only study on a dual-action therapy for diabetic macular edema found Hispanic and Latino patients not only ...

Lecap Asset Management Ltd. bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) ...